FDA Drugs (New Approvals & NDA)Original article
Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates
RegulatoryStarter Parenteral Nutrition Drug ProductsNeutral
AI Analysis
Summary
The FDA issued temporary policies describing its regulatory and enforcement priorities for compounding starter parenteral nutrition drug products for neonates by outsourcing facilities and state-licensed pharmacies.
Outcome Details
FDA issued temporary policies for compounding starter parenteral nutrition drug products for neonates by outsourcing facilities and state-licensed pharmacies
Importance:2/10
Sentiment:
0.00
FDA GuidanceCompoundingParenteral NutritionNeonatesRegulatory
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 4, 2026 8:26 PM